Text Size A A A

Print Home »

Erik Zwicker

Erik Zwicker, J.D., joined our Company in April 2020 as Vice President, General Counsel and Secretary. He is currently responsible for the Company’s global legal function. Prior to joining Taro, Mr. Zwicker was Head of Legal and Chief Compliance Officer at Roivant Sciences, Inc., a global pharmaceutical company. Prior to Roivant, Mr. Zwicker was Deputy Chief Governance Officer at Bridgewater Associates, LP. In addition, Mr. Zwicker’s experience includes serving as an Assistant U.S.

Michele Visosky

Michele Visosky joined our Company in January 2004 in the Human Resources department. She is currently Vice President, Head of Human Resources and heads the department in Canada, Israel and the United States. Ms. Visosky has over 27 years of human resources experience, the majority of which were spent in management level roles. Prior to joining Taro, Ms. Visosky worked at Micro Warehouse, Inc.

Hagai Reingold

Hagai Reingold joined the Company in August 2002 and currently serves as Vice President, Head of Operations. Mr. Reingold is the operations lead for our Israeli and Canadian manufacturing facilities. He is responsible for Pharma and API Manufacturing, Supply Chain Management, Engineering and Environmental Health and Safety (EH&S). Mr. Reingold also provides leadership and guidance in sales and marketing, human resources, IT and finance. Previously Mr.

Karen Lowney

Karen Lowney joined our Company as Associate Vice President, Head of the Office of Ethics & Compliance for Taro and Sun Pharma North America in October 2020.  She is responsible for designing, implementing and maintaining an effective compliance program and fostering an ethical, values-based culture. Ms. Lowney previously held compliance and privacy leadership positions within the life sciences industry at Astellas, Cephalon and Schering Plough.

David Kinzelberg

David Kinzelberg, CPA, joined our Company in July 2018 and serves as the Head of Internal Audit.  Mr. Kinzelberg has over 25 years of finance, audit, risk management, and operations experience. Prior to joining Taro, he served as the Coverage CFO for MSCI, a leading index and risk services provider. Mr.

Moshe Gavrilov

Moshe Gavrilov joined our Company in January 2022 as Vice President, Head of Commercial Israel and Rest of World. Mr. Gavrilov has more than 20 years of experience in the healthcare industry with a position in several medical devises and pharmaceuticals. Prior to joining Taro, he held progressively responsible positions within Teva Pharmaceuticals, including roles in supply chain, portfolio management and commercial operations.

William J. Coote

William J. Coote was appointment Vice President, Chief Financial Officer and Chief Accounting Officer, in December 2021.Mr. Coote has over 25 years of significant financial executive experience, most recently serving as Taro’s AVP, Treasurer and Business Finance since 2008. Prior to joining Taro, Mr.

Victoria Chester

Victoria Chester joined our Company in January 2021 as Vice President, Head of Quality. Ms. Chester has over 20 years of senior executive experience in Quality Operations, most recently serving as Vice President, Head of Corporate Quality Policies and Training in Sun Pharma from September 2016 to January 2021. Since 2007, Ms. Chester held senior roles as Global Director, Quality Policies and Systems in Apotex Inc. and Director of Global Quality Systems and Standards in Novartis Consumer Health Inc.

Avi Avramoff, Ph.D.

Avi Avramoff, Ph.D., joined our Company in October 2011 as Vice President, Head of Research & Development. He is responsible for the Company’s generic and innovative new product development, the management of the R&D Pharma and Chemistry, R&D Analytical Laboratories, Preclinical, Pharmacokinetic and Clinical Studies, Regulatory Affairs, R&D Project Management and Pharmacovigilance in all of Taros’ sites.

Vikash Agarwal

Vikash Agarwal joined our Company in December 2020 as Vice President, Head of Business Development. Prior to joining Taro, Mr.

Pages